The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIIT.L Regulatory News (IIT)

  • There is currently no data for IIT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

14 Jan 2022 09:29

RNS Number : 4895Y
Independent Investment Trust PLC
14 January 2022
 

RNS Announcement: Preliminary Results

 

The Independent Investment Trust PLC

 

The following is the unaudited preliminary statement of annual results for the year to 30 November 2021 which was approved by the board on 13 January 2022.

 

Chairman's Statement

 

Over the year to 30 November 2021, our company produced a net asset value (NAV) total return of 14.4%. Over the same period, theoretical investments in the FTSE All-Share Index and the FTSE World Index would have produced total returns of 17.4% and 22.3% respectively. This disappointing result is the product of very poor performance in the last ten weeks of our year, over which period we underperformed the FTSE All-Share Index by more than 7%. It is too early to offer a confident assessment of how much of this underperformance is attributable to fundamental developments at our holdings, but our current impression is that a change in market sentiment was an important element behind it.

The resulting decline in the popularity of our shares saw the discount move up from 7.7% at 30 November 2020 to 12.0% at 30 November 2021, producing a share price total return of 9.3%.

In general, the year 2021 was one of strong recovery for the world economy, although the Covid-19 pandemic continued to cast a long shadow over areas such as the travel industry. The speed of the recovery exposed capacity constraints in the shipping industry, which led to spectacular inflation in freight rates and a general disruption of supply lines. With further pressure from energy prices, and expansive monetary policy, inflation has been, and continues to be, much stronger than many had expected. Central banks would normally have been expected to react to these developments by tightening policy to a greater extent than they have, but fears over the robustness of the recovery in the face of regular mutations of the virus have stayed their hands. Investors have applauded this policy stance and markets have performed strongly.

The one major change in the industrial distribution of the portfolio was the emergence of the Business Services sector as our second biggest on the back of purchases of Bytes Technology and Big Technologies (both through initial public offerings) and strong share price performances from all three of our holdings. Our cash balances at 30 November 2021 amounted to 12.5%, down from 19.2% at 30 November 2020. Further comments on the portfolio can be found in the Managing Director's Report below.

Our performance over the last four years has not been good, but earlier triumphs mean that our long term record still bears comparison: for the period from inception in October 2000 to 30 November 2021, we produced an NAV total return of 861%, equivalent to a rate of roughly 11.4% per annum, of which 2.9% per annum can be offset by RPI inflation. By comparison, the notional return available from the FTSE All-Share Index over the period amounted to 183%, or 5.1% per annum.

Revenue earnings per share for the year were 9.61p (6.09p in 2020). With the reversion to our traditional practice of holding our AGM in March, we are proposing a final dividend of 5p, giving a regular dividend of 8p (8p in 2020). We are also declaring a special dividend of 1p to give a total dividend for the year of 9p (8p in 2020). Both will be paid on 8 April with an ex-dividend date of 10 March.

Our ongoing charges ratio fell from 0.27% to 0.24%. This maintains our position as one of the lowest cost - if not the lowest cost - actively managed investment trusts.

We have again been active in buying in our own shares: over the year we bought in rather over 1.3m shares at an average discount of 11.7%. We intend to continue the practice whenever we consider it to be in the interests of continuing shareholders.

Despite the disappointing performance of the portfolio, we remain pleased with the quality of its constituents. Most of them are trading well and those that are not are in a strong financial condition. Our chief concerns are not with our businesses but with the level of stockmarkets generally and with the risk that central banks may be misjudging the possibility of more durable inflation than they are currently anticipating.

We are currently planning to hold the AGM in the offices of Baillie Gifford at Calton Square at 4.30pm on 24 March 2022. It will help our planning if we know how many shareholders are likely to attend, and I shall be grateful if you will mark the proxy form accordingly and return it to the Company's registrars. I look forward to seeing as many of you as possible there. In the event that government regulations disrupt this plan, any changes will be posted on the Company's website independentinvestmenttrust.co.uk.

 

Douglas McDougall

13 January 2022

 

Past performance is not a guide to future performance.

For a definition of terms see Glossary of Terms and Alternative Performance Measures at the end of this announcement.

Total return information is sourced from Baillie Gifford /Refinitiv and relevant underlying index providers. See disclaimer at the end of this announcement.

 

 

 

Managing Director's Report

 

Our performance over the year has been covered in the Chairman's Statement.

 

It has been a good year for our technology holdings. Worth £69.8m at 30 November 2020, they had grown in value to £70.3m by 30 November 2021 after net sales of £15.6m. The two biggest contributors were Herald, which benefited from an excellent underlying portfolio performance, and Seeing Machines, which has been enjoying a sharp increase in interest in its technology after the hiatus caused by the pandemic. Alfa Financial Software and Zoo Digital both staged strong recoveries from depressed valuations on the back of favourable trading news with Zoo being sold on grounds of valuation. FDM's business has shown encouraging signs of recovery, but a sense that much of this had already been discounted led us to reduce the holding. Gamma Communications continued to deliver strong results, but its share price fell disappointingly in the second half of our year. Blue Prism was bid for towards the end of our year. The level of the bid was disappointing, but we had already realized big profits on the holding over the years. The digital services business Made Tech, bought at its initial public offering (IPO), made a disappointing start as concerns emerged over wage inflation in the technology industry.

Two new purchases (both at IPO) and strong all round share price performances led to Business Services becoming our second largest sector. Midwich is enjoying a strong recovery in its business, which was reflected in its share price performance. The relative lack of liquidity in the market for its shares prompted us to take advantage of this and realize some profits. The share price of Bytes Technology, one of the UK's leading software distributors, all but doubled between the time of our purchase and 30 November 2021 on the back of better trading than was generally expected. Big Technologies has developed electronic tags which are currently being deployed to monitor criminals, but which also have potential applications in healthcare. Their tags are significantly more reliable than most other tags on the market, which has led to very strong new business flows. Overall, the value of our Business Services holdings grew from £12.1m on 30 November 2020 to £53.8m at 30 November 2021 after net purchases of £19.7m.

It was a brutal year for our Travel and Leisure holdings: despite net purchases of £13.7m, the value of our stake had only increased from £47.6m at 30 November 2020 to £51.8m at 30 November 2021. Our holiday companies, Jet2 and On The Beach were particularly badly hit as hopes of a lifting of travel restrictions were continually deferred. We believe both will perform well once restrictions are finally lifted, not least because so many competitors have had to retrench. Our computer gaming companies also had a difficult time after their strong showing in 2020. In the case of Team 17 and tinyBuild, trading news was in line with expectations, but Frontier Developments suffered disappointments with some of its new launches. The one bright spot was the café bar operator, Loungers, which traded strongly whenever it was allowed to open.

After a dismal performance last year, our housebuilding holdings showed something of a return to form in the year under review: a stake worth £28.6m at 30 November 2020 had grown in value to £33.6m by 30 November 2021 after net purchases of £0.4m. As the year started many were expecting a subdued housing market in 2021, arguing that the ending of stamp duty relief and the tightening of Help to Buy restrictions would take the wind out of a market widely thought to have over-reached itself in the exuberance of its post covid recovery. In the event, long term structural demand combined with good levels of affordability to produce one of the strongest housing markets in recent years, at least in terms of pricing. Supply remained a problem with many housebuilders suffering planning delays, but all our holdings are on track to produce good results for the year. Their share prices were strong throughout the first half of the year, but then succumbed to fears of rising interest rates. As has often been the case in the past, we find ourselves struggling to envisage the scale of setback to their prospects that now appears discounted in their valuations.

Our renewed enthusiasm for the retail sector has turned out to be at best premature: a stake worth £6.2m at 30 November 2020 grew in value to £19.3m by 30 November 2021, but that was only after net purchases of £19.7m. Motorpoint, the only retail holding at the start of the period, delivered a strong fundamental performance and a satisfactory share price performance as it embarked upon its transition towards becoming a retailer with equal strengths online and offline. Our three new purchases, the online retailers Victorian Plumbing, Moonpig and Seraphine, all delivered disappointing share price performances. In the case of Victorian Plumbing sales disappointed after the end of lockdown; in the case of Seraphine, a specialist in maternity wear, a temporary supply chain glitch disrupted its first half sales and profits, but appears not to have had any lasting ill effects; and in the case of Moonpig, sales and profits above management's predictions (albeit below the levels of the preceding year) were not enough to prevent the share price from falling.

In the healthcare area, good share price performances led us to sell out of Oxford Biomedica at a good profit and to reduce our holding in Medica, which has been a disappointing investment. We also bought a small holding in Synairgen, which is carrying out phase 3 trials on a product which might have a big role to play in treating serious covid cases. In tobacco, we sold out of Imperial Brands at a good profit, but made only a modest return in our holding in British American.

Elsewhere in the portfolio, the strong performance of Ashtead after we bought it back merely illustrated the scale of our mistake in selling it early in the pandemic. Telecom Plus performed disappointingly for much of the year, but came to life when many of its most troublesome competitors found themselves in financial difficulties. We made a further reduction in our Fever-Tree holding purely on grounds of valuation and we sold out of Derwent London at a small profit. Finally, while our longstanding holding in Polar Capital Global Insurance had a satisfactory year, our big holding in Direct Line performed poorly as investors switched their attention to more exciting stories.

 

Max Ward

13 January 2022

 

 

Past performance is not a guide to future performance.

 

 

 

List of Investments as at 30 November 2021 (unaudited)

 

Sector

Name

2020

Value

£'000

 

Net transactions

£'000

 

Gains/ (losses)

£'000

 

2021

Value

£'000

 

%

Housing

Bellway

 11,320

 

 -

 

 1,152

 

 12,472

 

 3.8

 

Persimmon

 6,906

 

 374

 

 931

 

 8,211

 

 2.5

 

Redrow

 10,380

 

 -

 

 2,576

 

 12,956

 

 4.0

 

 

 28,606

 

 374

 

 4,659

 

 33,639

 

 10.3

Industrials

Ashtead Group

-

 

3,800 

 

5,266 

 

9,066

 

2.8

Retailing

Moonpig Group

 -

 

 5,280

 

(366)

 

 4,914

 

 1.5

 

Motorpoint

 6,200

 

(1,870)

 

 620

 

 4,950

 

 1.5

 

Seraphine Group

 -

 

 4,498

 

(2,119)

 

 2,379

 

 0.7

 

Victorian Plumbing

 -

 

 11,790

 

(4,770)

 

 7,020

 

 2.2

 

Alibaba Group

 -

 

(6)

 

 6

 

 -

 

 -

 

 

 6,200

 

 19,692

 

(6,629)

 

 19,263

 

 5.9

Consumer Services

Telecom Plus

8,580

 

(343)

 

(74)

 

8,163

 

2.5

Travel and Leisure

Frontier Developments

 9,158

 

(2,726)

 

(1,519)

 

 4,913

 

 1.5

 

Jet2

 -

 

 11,978

 

(2,220)

 

 9,758

 

 3.0

 

Loungers

 3,737

 

 -

 

 979

 

 4,716

 

 1.5

 

On the Beach Group

 11,580

 

(3,841)

 

(3,080)

 

 4,659

 

 1.4

 

Team 17 Group

 23,100

 

(1,654)

 

(3,526)

 

 17,920

 

 5.5

 

tinyBuild

 

9,993 

 

(193)

 

9,800

 

3.0

 

 

 47,575

 

 13,750

 

(9,559)

 

 51,766

 

 15.9

Business Services

Big Technologies

 -

 

 10,250

 

 3,280

 

 13,530

 

 4.1

 

Bytes Technology Group

 -

 

 14,207

 

 13,443

 

 27,650

 

 8.5

 

Midwich

 12,100

 

(4,760)

 

 5,260

 

 12,600

 

 3.9

 

 

 12,100

 

 19,697

 

 21,983

 

 53,780

 

 16.5

Tobacco

Imperial Brands

 9,527

 

(10,718)

 

 1,191

 

 -

 

 -

 

British American Tobacco

 10,556

 

 -

 

(438)

 

 10,118

 

 3.1

 

 

 20,083

 

(10,718)

 

 753

 

 10,118

 

 3.1

Technology and

Alfa Financial Software

 3,255

 

 -

 

 1,645

 

 4,900

 

 1.5

Telecommunications

Blue Prism

 7,135

 

(6,026)

 

 255

 

 1,364

 

 0.4

 

FDM Group

 15,360

 

(5,387)

 

 1,247

 

 11,220

 

 3.4

 

Gamma Communications

 11,235

 

 -

 

 651

 

 11,886

 

 3.7

 

Herald Investment Trust

 24,700

 

(4,748)

 

 6,228

 

 26,180

 

 8.0

 

Made Tech Group

 -

 

 5,671

 

(919)

 

 4,752

 

 1.5

 

Seeing Machines

 6,784

 

(2,998)

 

 6,239

 

 10,025

 

 3.1

 

Zoo Digital Group

 1,300

 

(2,160)

 

 860

 

 -

 

 -

 

 

 69,769

 

(15,648)

 

 16,206

 

 70,327

 

 21.6

Beverages

Fever-Tree Drinks

9,240

 

(4,544)

 

484 

 

5,180

 

1.6

Insurance

Direct Line Insurance Group

14,785

 

 

(1,265)

 

13,520

 

4.1

Property

Derwent London

6,080

 

(6,842)

 

762 

 

-

 

-

Healthcare

Medica Group

 4,920

 

(3,111)

 

 1,391

 

 3,200

 

 1.0

 

Oxford Biomedica

 6,027

 

(7,637)

 

 1,610

 

 -

 

 -

 

Synairgen

 -

 

 923 

 

 291

 

 1,214

 

 0.4

 

 

 10,947

 

(9,825)

 

 3,292

 

 4,414

 

 1.4

Financials

Polar Capital Global Insurance Fund - Ireland

5,325

 

 

614 

 

5,939

 

1.8

Total Investments

 

 239,290

 

 9,393

 

 36,492

 

 285,175

 

 87.5

Net Liquid Assets

 

 56,970

 

(16,044)

 

 -

 

 40,926

 

 12.5

Shareholders' Funds

 

 296,260

 

(6,651)

 

 36,492

 

 326,101

 

 100.0

 

All holdings are in equities domiciled in the UK unless otherwise stated.

 

 

 

Income statement

 

 

For the year ended

30 November 2021 (unaudited)

For the year ended

30 November 2020 (audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains/(losses) on investments

36,492 

36,492 

(10,371)

(10,371)

Currency (losses)/gains

(20)

(20)

22 

22 

Income (note 2)

5,917 

5,917 

4,070 

4,070 

Administrative expenses

(798)

(798)

(743)

(743)

Net return on ordinary activities before taxation

5,119 

36,472 

41,591 

3,327 

(10,349)

(7,022)

Tax on ordinary activities

(5)

-

(5)

Net return on ordinary activities after taxation

5,119 

36,472 

41,591 

3,322 

(10,349)

(7,027)

Net return per ordinary share (note 3)

9.61p

68.46p

78.07p

6.09p

(18.98p)

(12.89p)

Note:

Dividends per share paid and payable in respect of the year (note 4)

9.00p

 

 

8.00p

 

 

 

 

The total column of this statement is the profit and loss account of the Company. The supplementary revenue and capital columns are prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in this statement derive from continuing operations.

A Statement of Comprehensive Income is not required as the Company does not have any other comprehensive income and the net return on ordinary activities after taxation is both the profit and comprehensive income for the year.

 

 

Balance sheet

 

 

At 30 November 2021 (unaudited)

At 30 November 2020 (audited)

 

£'000

£'000

£'000

£'000

Fixed assets

 

 

 

 

Investments held at fair value through profit or loss

 

285,175 

 

239,290

Current assets

 

 

 

 

Debtors

135 

 

921 

 

Cash and cash equivalents

40,878 

 

56,237 

 

 

41,013 

 

57,158 

 

Creditors

 

 

 

 

Amounts falling due within one year

(87)

 

(188)

 

Net current assets

 

40,926 

 

56,970

Total net assets

 

326,101 

 

296,260

 

 

 

 

 

Capital and reserves

 

 

 

 

Share capital

 

13,193 

 

13,539

Share premium account

 

15,242 

 

15,242

Special distributable reserve

 

2,503 

 

9,985

Capital redemption reserve

 

3,339 

 

2,993

Capital reserve

 

284,894 

 

248,422

Revenue reserve

 

6,930 

 

6,079

Shareholders' funds

 

326,101 

 

296,260

Net asset value per ordinary share (note 5)

 

617.9p

 

547.1p

 

 

 

Statement of changes in equity

 

For the year ended 30 November 2021 (unaudited)

 

 Share capital

£'000

Share premium account

£'000

Special distributable reserve

£'000

Capital redemption reserve

£'000

Capital

reserve*

£'000

Revenue reserve

£'000

 

Shareholders'funds

£'000

Shareholders' funds at 1 December 2020

13,539

15,242

9,985 

2,993

248,422 

6,079

296,260 

Net return on ordinary activities after taxation

-

-

-

-

36,472 

5,119

41,591 

Shares bought back for cancellation (note 5)

(346)

-

(7,482)

346

-

(7,482)

Dividends paid during the year

(note 4)

-

-

-

(4,268) 

(4,268)

Shareholders' funds at 30 November 2021

13,193

15,242

2,503

3,339

284,894 

6,930

326,101 

 

For the year ended 30 November 2020 (audited)

 

Share capital

£'000

Share premium account

£'000

Special distributable reserve

£'000

Capital redemption reserve

£'000

Capital

reserve*

£'000

Revenue reserve

£'000

 

Shareholders'funds

£'000

Shareholders' funds at 1 December 2019

13,679 

15,242

12,465 

2,853

258,771 

9,859

312,869

Net return on ordinary activities after taxation

-

-

(10,349)

3,322

(7,027)

Shares bought back for cancellation (note 5)

(140)

-

(2,480)

140

-

(2,480)

Dividends paid during the year

(note 4)

-

-

(7,102) 

(7,102)

Shareholders' funds at 30 November 2020

13,539 

15,242

9,985 

2,993

248,422 

6,079

296,260

 

* The Capital Reserve balance at 30 November 2021 included an investment holding gain of £95,883,000 (2020 - gain of £95,283,000).

 

 

Notes to Financial Statements (unaudited)

 

1.

The unaudited financial statements for the year to 30 November 2021 have been prepared in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' on the basis of the accounting policies set out in the Annual Report and Financial Statements are unchanged from the prior year and have been applied consistently. All of the Company's operations are of a continuing nature and the financial statements are expected to be prepared on a going concern basis. The Company has elected not to present a Statement of Cash Flows for the current year as a Statement of Changes in Equity has been provided and substantially all of the Company's investments are highly liquid and are carried at market value.

2.

Income

Year to

30 November 2021

Year to

30 November 2020

 

 

£'000

 

£'000

Income from investments

 

 

 

 

UK dividends

 

5,820

 

3,880

Overseas dividends

 

78

 

122

 

 

 

5,898

 

4,002

 

 

 

 

 

 

 

Other income

 

 

 

 

 

Deposit interest

 

2

 

51

 

Other income

 

17

 

17

 

 

 

19

 

68

 

Total income

 

5,917

 

4,070

 

Total income comprises:

 

 

 

 

 

Dividends from financial assets designated through profit or loss

 

5,898

 

4,002

 

Deposit interest

 

2

 

51

 

Other income

 

17

 

17

 

 

 

5,917

 

4,070

 

 

 

 

3.

Net return per ordinary share

Year to

30 November 2021

Year to

30 November 2020

 

Revenue

Capital

Total

Revenue

Capital

Total

 

Net return on ordinary activities after taxation (£'000)

5,119

36,472

41,591

3,322

(10,349)

(7,027)

 

Weighted average number of ordinary shares in issue during the year

53,274,238

54,527,195

 

Net return per ordinary share

9.61p

68.46p

78.07p

6.09p

(18.98p)

(12.89p)

 

Returns per ordinary share are based on the return for the financial year and on the weighted average number of ordinary shares in issue during the year as shown above.

There are no dilutive or potentially dilutive shares in issue.

            

 

 

 

 

 

 

Notes to Financial Statements (unaudited) (Ctd)

 

4.

Ordinary dividends

Year to

30 November 2021

Year to

30 November 2020

 

Pence

£'000

Pence

£'000

Amounts recognized as distributions in the year

 

 

 

 

Previous year's final dividend paid 9 April 2021 (2020 - 6 April 2020)

5.00

2,674

5.00

2,734

Previous year's special dividend (2020 - 6 April 2020)

-

-

5.00

2,734

Interim dividend paid 20 August 2021 (2020 - 21 August 2020)

3.00

1,594

3.00

1,634

 

8.00

4,268

13.00

7,102

 

Set out below are the total dividends paid and proposed in respect of the financial year, which is the basis on which the requirements of section 1158 of the Corporation Tax Act 2010 are considered. The revenue available for distribution by way of dividend for the year is £5,119,000 (2020 - £3,322,000).

 

 

Year to

30 November 2021

Year to

30 November 2020

 

Pence

£'000

Pence

£'000

Amounts paid and payable in respect of the year

 

 

 

 

Interim dividend paid 20 August 2021 (2020 - 21 August 2020)

3.00

1,594

3.00

1,634

Final/second interim dividend paid 8 April 2022 (9 April 2021)

5.00

2,638

5.00

2,708

Special dividend

1.00

528

-

-

 

9.00

4,760

8.00

4,342

 

5.

Net asset value per ordinary share

At 30 November 2021

Pence

At 30 November 2021

£'000

At 30 November 2020

Pence

At 30 November 2020

£'000

 

Ordinary shares

617.9

326,101

547.1

296,260

 

The net asset value per share is based on net assets as shown above and on 52,773,681 shares (2020 - 54,155,657), being the number of shares in issue at the year end.

There are no dilutive or potentially dilutive shares in issue.

6.

Transaction costs incurred on the purchase and sale of the investments are added to the purchase cost or deducted from the sale proceeds, as appropriate. During the year, transaction costs on purchases amounted to £208,000 (2020 - £569,000) and transaction costs on sales amounted to £183,000 (2020 - £224,000) respectively.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes to Financial Statements (unaudited) (Ctd)

7.

The financial information set out above does not constitute the Company's statutory accounts for the year ended 30 November 2021. The financial information for 2020 is derived from the financial statements for 2020 which have been delivered to the Registrar of Companies. The auditors have reported on the 2020 accounts; their report was unqualified, did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying the report and did not contain a statement under sections 498 (2) or 498(3) of the Companies Act 2006. The statutory accounts for 2021 will be finalised on the basis of the financial information presented in this preliminary announcement and will be delivered to the Registrar of Companies following the Company's Annual General Meeting. The Auditors have advised the Company that they do not expect their report on the 2021 statutory accounts to include any modification or emphasis of matter statements.

8.

The Report and Accounts will be available on the Company's website independentinvestmenttrust.co.uk on or around 18 February 2022.

 

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

None of the views expressed in this document should be construed as advice to buy or sell a particular investment.

 

Glossary of Terms and Alternative Performance Measures (APM)

 

Total Assets

The total value of all assets held less all liabilities (other than liabilities in the form of borrowings).

Net Asset Value

Net Asset Value (NAV) is the value of all assets held less all liabilities (including liabilities in the form of borrowings). The NAV per share is calculated by dividing this amount by the number of ordinary shares in issue.

(Discount)/Premium (APM)

As stockmarkets and share prices vary, an investment trust's share price is rarely the same as its NAV. When the share price is lower than the NAV per share it is said to be trading at a discount. The size of the discount is calculated by subtracting the share price from the NAV per share and is usually expressed as a percentage of the NAV per share. If the share price is higher than the NAV per share, this situation is called a premium.

 

As at 30 November

 

2021

2020

Net asset value per share

(a)

617.9p

547.1p

Share price

(b)

544.0p

505.0p

(Discount)

((b)-(a))/(a)

(12.0%)

(7.7%)

 

Net Liquid Assets

Net liquid assets comprise current assets less current liabilities (excluding borrowings).

Total Return (APM)

The total return is the return to shareholders after reinvesting the net dividend on the date that the share price goes ex-dividend.

 

 

 

 

 

Glossary of Terms and Alternative Performance Measures (APM) (Ctd)

 

Net Asset Value

 

 

2021

2020

Opening NAV per share at 1 December 2020 (2019)

(a)

547.1p

571.8p

Closing NAV per share at 30 November

(b)

617.9p

547.1p

Total dividend adjustment factor*

(c)

1.01321

1.02242

Adjusted closing NAV per share (d = b x c)

(d)

626.1p

559.3p

Total return on net asset value (d - a) ÷ a expressed as a percentage

 

14.4%

(2.2%)

 

* The dividend adjustment factor is calculated on the assumption that the dividends paid out by the Company are reinvested into shares of the Company at the cum income NAV at the ex-dividend date.

 

Share Price

 

 

2021

2020

Opening share price at 1 December 2020 (2019)

(a)

505.0p

518.0p

Closing share price at 30 November

(b)

544.0p

505.0p

Total dividend adjustment factor*

(c)

1.01506

1.02409

Adjusted closing share price (d = b x c)

(d)

552.2p

517.2p

Total return on share price (d - a) ÷ a expressed as a percentage

 

9.3%

(0.2%)

 

* The dividend adjustment factor is calculated on the assumption that the dividends paid out by the Company are reinvested into shares of the Company at the last traded price quoted at the ex-dividend date.

 

Ongoing Charges (APM)

The total administrative expenses incurred by the Company as a percentage of the average shareholders' funds, calculated on a daily basis.

 

 

2021

£'000

2020

£'000

Total administrative expenses (a)

798

743

Average net asset value (b)

329,989

277,403

Ongoing charges (a) ÷ (b) expressed as a percentage

0.24%

0.27%

 

Available cash (APM)

Cash and cash equivalents as adjusted for investment and share buy-back transactions awaiting settlement.

 

Compound Annual Return

The compound annual return converts the return over a period of longer than one year to a constant annual rate of return applied to the compounded value at the start of each year.

 

 

 

 

Third Party Data Provider Disclaimer

No third party data provider ('Provider') makes any warranty, express or implied, as to the accuracy, completeness or timeliness of the data contained herewith nor as to the results to be obtained by recipients of the data. No Provider shall in any way be liable to any recipient of the data for any inaccuracies, errors or omissions in the index data included in this document, regardless of cause, or for any damages (whether direct or indirect) resulting therefrom. No Provider has any obligation to update, modify or amend the data or to otherwise notify a recipient thereof in the event that any matter stated herein changes or subsequently becomes inaccurate. Without limiting the foregoing, no Provider shall have any liability whatsoever to you, whether in contract (including under an indemnity), in tort (including negligence), under a warranty, under statute or otherwise, in respect of any loss or damage suffered by you as a result of or in connection with any opinions, recommendations, forecasts, judgements, or any other conclusions, or any course of action determined, by you or any third party, whether or not based on the content, information or materials contained herein.

 

FTSE Index data

FTSE International Limited ('FTSE') © FTSE 2021. 'FTSE®' is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under licence. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data and no party may rely on any FTSE indices, ratings and/or data underlying data contained in this communication. No further distribution of FTSE Data is permitted without FTSE's express written consent. FTSE does not promote, sponsor or endorse the content of this communication.

 

Legal Entity Identifier: 213800IYHGJTZJ3MO642

Regulated Information Classification: Additional regulated information required to be disclosed under applicable laws

 

- ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR BKQBBCBKKBDD
Date   Source Headline
3rd Nov 202210:45 amRNSNet Asset Value(s)
2nd Nov 202210:41 amRNSNet Asset Value(s)
1st Nov 202212:33 pmRNSNet Asset Value(s)
31st Oct 20222:02 pmRNSResult of Meeting
31st Oct 202210:48 amRNSNet Asset Value(s)
28th Oct 202210:59 amRNSNet Asset Value(s)
27th Oct 202210:35 amRNSNet Asset Value(s)
26th Oct 202210:57 amRNSNet Asset Value(s)
25th Oct 202212:01 pmRNSNet Asset Value(s)
24th Oct 20225:30 pmRNSIndependent Investment Trust PLC
24th Oct 202210:21 amRNSNet Asset Value(s)
21st Oct 202211:17 amRNSNet Asset Value(s)
20th Oct 202211:06 amRNSNet Asset Value(s)
19th Oct 202210:05 amRNSNet Asset Value(s)
18th Oct 202211:17 amRNSNet Asset Value(s)
17th Oct 202211:21 amRNSNet Asset Value(s)
17th Oct 202211:21 amRNSNet Asset Value(s)
14th Oct 202212:32 pmRNSNet Asset Value(s)
13th Oct 202210:32 amRNSNet Asset Value(s)
12th Oct 202210:18 amRNSNet Asset Value(s)
11th Oct 202210:48 amRNSNet Asset Value(s)
10th Oct 202211:03 amRNSNet Asset Value(s)
7th Oct 202210:12 amRNSNet Asset Value(s)
6th Oct 202211:39 amRNSPre-liquidation interim dividend
6th Oct 202211:33 amRNSPublication of a Circular
6th Oct 202210:15 amRNSNet Asset Value(s)
5th Oct 202210:43 amRNSNet Asset Value(s)
4th Oct 202210:21 amRNSNet Asset Value(s)
3rd Oct 202211:48 amRNSNet Asset Value(s)
30th Sep 202212:33 pmRNSNet Asset Value(s)
29th Sep 202211:00 amRNSNet Asset Value(s)
28th Sep 202212:18 pmRNSNet Asset Value(s)
27th Sep 202210:44 amRNSNet Asset Value(s)
26th Sep 202211:39 amRNSNet Asset Value(s)
23rd Sep 202211:18 amRNSNet Asset Value(s)
22nd Sep 202210:52 amRNSNet Asset Value(s)
21st Sep 202211:53 amRNSNet Asset Value(s)
20th Sep 202212:37 pmRNSNet Asset Value(s)
20th Sep 202210:42 amRNSNet Asset Value(s)
16th Sep 202211:09 amRNSNet Asset Value(s)
15th Sep 202211:19 amRNSNet Asset Value(s)
14th Sep 202210:31 amRNSNet Asset Value(s)
13th Sep 202211:26 amRNSNet Asset Value(s)
12th Sep 202210:47 amRNSNet Asset Value(s)
9th Sep 202211:24 amRNSNet Asset Value(s)
8th Sep 202210:04 amRNSNet Asset Value(s)
7th Sep 202211:10 amRNSNet Asset Value(s)
6th Sep 202211:19 amRNSNet Asset Value(s)
5th Sep 202210:52 amRNSNet Asset Value(s)
2nd Sep 202212:43 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.